HORIZON (OP-106): melflufen plus dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM) refractory to pomalidomide and/or an anti-CD38 monoclonal antibody - primary and subgroup analysis

Autores: Richardson, P. ; Oriol, A.; Larocca, A.; Blade, J. ; Cavo, M.; Rodríguez Otero, Paula; Leleu, X.; Norkin, M. ; Nadeem, O.; Hiemenz, J. ; Hassoun, H. ; Touzeau, C.; Alegre, A. ; Paner, A. ; Maisel, C.; Mazumder, A.; Raptis, A.; Puig, N. ; Byrne, C.; Mateos, M. V.